VOV.VN - Chronic kidney disease, once predominantly seen in older adults, is now increasingly affecting younger people in ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

A recent survey suggests a widening gut-health gap, with women—often the default planners and hosts—bearing the brunt of ...

A check mark. It indicates that the relevant content has been reviewed and verified by an expert Our stories are reviewed by medical professionals to ensure you get the most accurate and useful ...